| 111 |
Sildenafil and furosemide nanoparticles as a novel pharmacological treatment for acute renal failure in rats |
Department of Pharmacology |
2025 |
| 112 |
Structure-Based Design and Synthesis of 3-Spiroindolin-2-one Derivatives as Potential Anticancer Agents |
Department of Medicinal Chemistry |
2025 |
| 113 |
Structure-based design of benzofuran library as P. aeruginosa Quorum sensing inhibitors: Synthesis, biological evaluation and Molecular docking study. |
Department of Medicinal Chemistry |
2025 |
| 114 |
Switchable nanozyme-based colorimetric assay for protamine and heparin using silver citrate nanoparticles |
|
2025 |
| 115 |
Synthesis and characterization of sodium alginate/poly (N-vinylpyrrolidone) nano-carrier loaded with rebaudioside A and/or stevioside for anticancer drug delivery |
Department of Pharmacognosy |
2025 |
| 116 |
Synthesis and SARs of benzimidazoles: insights into antimicrobial innovation (2018–2024) |
Department of Medicinal Chemistry |
2025 |
| 117 |
Synthesis, characterization and antimicrobial activity of new 1,2,4-triazole and pyridine derivatives bearing methyl 4-aminosalicylate moiety as a substructure |
Department of Pharmaceutical Organic Chemistry |
2025 |
| 118 |
Targeting melanoma resistance: Novel oxindole and non-oxindole-based benzimidazole derivatives as potent dual inhibitors of BRAFV600E and ABL2 kinases |
Department of Medicinal Chemistry |
2025 |
| 119 |
Towards development of luminescent silver-based metal organic frameworks for selective detection of trifluralin |
Department of Pharmaceutical Analytical Chemistry |
2025 |
| 120 |
Transdermal delivery of doxorubicin-loaded lyotropic liquid crystals formulations for enhanced drug skin deposition and cytotoxicity against MCF-7 breast cancer cells |
Department of Pharmaceutics |
2025 |
Do you have any questions? (088) 2080369 - 2345622 Pharmacy_QAAU@pharm.aun.edu.eg
